Filing Details
- Accession Number:
- 0000905718-20-000119
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 19:24:36
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 19:24:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1504167 | Biopharmx Corp | BPMX | Pharmaceutical Preparations (2834) | 593843182 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1800690 | Tardimed Sciences Llc | 50 Tice Boulevard, Suite A26 Woodcliff Lake NJ 07677 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2020-02-10 | 2,255,336 | $0.01 | 2,255,336 | No | 4 | X | Indirect | See Footnote |
Common Stock, Par Value $0.01 Per Share | Disposition | 2020-02-10 | 55,008 | $0.01 | 2,200,328 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Warrant (right to buy) | Disposition | 2020-02-10 | 2,225,336 | $0.00 | 2,255,336 | $0.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-01-28 | 2022-07-28 | No | 4 | X | Indirect |
Footnotes
- The reported securities are held by Timber Pharmaceuticals LLC, a Delaware limited liability company ("Timber"). TardiMed Sciences LLC, a Connecticut limited liability company (the "Reporting Person"), owns a 90% interest in Timber. The Reporting Person disclaims beneficial ownership of the BioPharmX Corporation ("BioPharmX") common stock underlying the reported securities held by Timber except to the extent of its pecuniary interest therein.
- On February 10, 2020, Timber exercised a warrant to purchase 2,255,336 shares of common stock, par value $0.01 per share (the "Warrant Shares"), of BioPharmX. Timber paid the exercise price on a cashless basis, resulting in BioPharmX's withholding of 55,008 of the Warrant Shares to pay the exercise price and issuing the remaining 2,200,328 Warrant Shares to Timber.